Grants and Contributions:
Title:
Germany ZIM project 3D Gewebe - Production and validation of multiple 3D-printed human contractile tissues
Agreement Number:
891779
Agreement Value:
$401,700.00
Agreement Date:
Aug 1, 2017 - Oct 31, 2020
Description:
This international collaborative project integrates innovative Canadian bioprinting technology with unique cell immortalization and tissue technology from Germany in order to generate and validate a portfolio of highly physiological and functional living bioprinted 3D human tissues.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6P 6P2
Reference Number:
172-2019-2020-Q2-891779
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
830167839
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days.
Amendment Date
Jun 16, 2020
Recipient's Legal Name:
Aspect Biosystems Ltd.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: